Free Trial

Tilray Brands (TLRY) Competitors

Tilray Brands logo
C$7.80 -0.28 (-3.47%)
As of 04:00 PM Eastern

TLRY vs. BHC, SLS, AUP, CARA, and CRON

Should you be buying Tilray Brands stock or one of its competitors? The main competitors of Tilray Brands include Bausch Health Companies (BHC), Solaris Resources (SLS), Aurinia Pharmaceuticals (AUP), Cara Operations (CARA), and Cronos Group (CRON). These companies are all part of the "pharmaceutical products" industry.

How does Tilray Brands compare to Bausch Health Companies?

Bausch Health Companies (TSE:BHC) and Tilray Brands (TSE:TLRY) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, media sentiment, risk, analyst recommendations, institutional ownership and dividends.

Tilray Brands has a consensus price target of C$13.30, suggesting a potential upside of 70.51%. Given Tilray Brands' higher possible upside, analysts clearly believe Tilray Brands is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch Health Companies
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Bausch Health Companies has higher revenue and earnings than Tilray Brands. Bausch Health Companies is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch Health CompaniesC$10.53B0.27-C$125.65M-C$3.24N/A
Tilray BrandsC$858.28M1.09-C$183.24M-C$14.63N/A

13.5% of Bausch Health Companies shares are held by institutional investors. Comparatively, 4.1% of Tilray Brands shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by insiders. Comparatively, 0.7% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Bausch Health Companies has a net margin of -13.54% compared to Tilray Brands' net margin of -158.75%. Bausch Health Companies' return on equity of 120.43% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch Health Companies-13.54% 120.43% 4.16%
Tilray Brands -158.75%-88.06%-1.41%

In the previous week, Bausch Health Companies had 2 more articles in the media than Tilray Brands. MarketBeat recorded 4 mentions for Bausch Health Companies and 2 mentions for Tilray Brands. Tilray Brands' average media sentiment score of 0.36 beat Bausch Health Companies' score of 0.22 indicating that Tilray Brands is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch Health Companies
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tilray Brands
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Bausch Health Companies has a beta of 0.588188, meaning that its stock price is 41% less volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 3.243166, meaning that its stock price is 224% more volatile than the S&P 500.

Summary

Bausch Health Companies beats Tilray Brands on 9 of the 14 factors compared between the two stocks.

How does Tilray Brands compare to Solaris Resources?

Solaris Resources (TSE:SLS) and Tilray Brands (TSE:TLRY) are both pharmaceutical products companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

Solaris Resources presently has a consensus price target of C$19.50, suggesting a potential upside of 47.17%. Tilray Brands has a consensus price target of C$13.30, suggesting a potential upside of 70.51%. Given Tilray Brands' higher probable upside, analysts plainly believe Tilray Brands is more favorable than Solaris Resources.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solaris Resources
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Solaris Resources has higher earnings, but lower revenue than Tilray Brands. Solaris Resources is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Solaris ResourcesN/AN/A-C$46.49M-C$0.26N/A
Tilray BrandsC$858.28M1.09-C$183.24M-C$14.63N/A

16.1% of Solaris Resources shares are owned by institutional investors. Comparatively, 4.1% of Tilray Brands shares are owned by institutional investors. 40.6% of Solaris Resources shares are owned by insiders. Comparatively, 0.7% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Solaris Resources has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Solaris Resources' return on equity of 96.23% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Solaris ResourcesN/A 96.23% -51.67%
Tilray Brands -158.75%-88.06%-1.41%

In the previous week, Tilray Brands had 1 more articles in the media than Solaris Resources. MarketBeat recorded 2 mentions for Tilray Brands and 1 mentions for Solaris Resources. Solaris Resources' average media sentiment score of 0.48 beat Tilray Brands' score of 0.36 indicating that Solaris Resources is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Solaris Resources
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tilray Brands
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Solaris Resources has a beta of 1.845161, indicating that its stock price is 85% more volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 3.243166, indicating that its stock price is 224% more volatile than the S&P 500.

Summary

Solaris Resources beats Tilray Brands on 9 of the 15 factors compared between the two stocks.

How does Tilray Brands compare to Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals (TSE:AUP) and Tilray Brands (TSE:TLRY) are both pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership and profitability.

In the previous week, Tilray Brands had 2 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 2 mentions for Tilray Brands and 0 mentions for Aurinia Pharmaceuticals. Tilray Brands' average media sentiment score of 0.36 beat Aurinia Pharmaceuticals' score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.

Company Overall Sentiment
Aurinia Pharmaceuticals Neutral
Tilray Brands Neutral

Aurinia Pharmaceuticals has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Aurinia Pharmaceuticals' return on equity of 0.00% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Aurinia PharmaceuticalsN/A N/A N/A
Tilray Brands -158.75%-88.06%-1.41%

4.1% of Tilray Brands shares are held by institutional investors. 0.7% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Tilray Brands has higher revenue and earnings than Aurinia Pharmaceuticals. Tilray Brands is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurinia PharmaceuticalsC$57.59M0.00-C$190.03M-C$1.48N/A
Tilray BrandsC$858.28M1.09-C$183.24M-C$14.63N/A

Tilray Brands has a consensus price target of C$13.30, indicating a potential upside of 70.51%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts plainly believe Tilray Brands is more favorable than Aurinia Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurinia Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Tilray Brands beats Aurinia Pharmaceuticals on 9 of the 13 factors compared between the two stocks.

How does Tilray Brands compare to Cara Operations?

Tilray Brands (TSE:TLRY) and Cara Operations (TSE:CARA) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

4.1% of Tilray Brands shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Tilray Brands currently has a consensus target price of C$13.30, indicating a potential upside of 70.51%. Given Tilray Brands' stronger consensus rating and higher possible upside, equities analysts clearly believe Tilray Brands is more favorable than Cara Operations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Cara Operations
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Tilray Brands had 2 more articles in the media than Cara Operations. MarketBeat recorded 2 mentions for Tilray Brands and 0 mentions for Cara Operations. Tilray Brands' average media sentiment score of 0.36 beat Cara Operations' score of 0.00 indicating that Tilray Brands is being referred to more favorably in the media.

Company Overall Sentiment
Tilray Brands Neutral
Cara Operations Neutral

Cara Operations has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Cara Operations' return on equity of 0.00% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-158.75% -88.06% -1.41%
Cara Operations N/A N/A N/A

Cara Operations has lower revenue, but higher earnings than Tilray Brands.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray BrandsC$858.28M1.09-C$183.24M-C$14.63N/A
Cara OperationsN/AN/AN/AN/AN/A

Summary

Tilray Brands beats Cara Operations on 7 of the 10 factors compared between the two stocks.

How does Tilray Brands compare to Cronos Group?

Cronos Group (TSE:CRON) and Tilray Brands (TSE:TLRY) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, media sentiment, earnings, risk and analyst recommendations.

In the previous week, Tilray Brands had 1 more articles in the media than Cronos Group. MarketBeat recorded 2 mentions for Tilray Brands and 1 mentions for Cronos Group. Tilray Brands' average media sentiment score of 0.36 beat Cronos Group's score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cronos Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tilray Brands
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

4.4% of Cronos Group shares are owned by institutional investors. Comparatively, 4.1% of Tilray Brands shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by insiders. Comparatively, 0.7% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Cronos Group presently has a consensus target price of C$4.38, indicating a potential upside of 21.53%. Tilray Brands has a consensus target price of C$13.30, indicating a potential upside of 70.51%. Given Tilray Brands' higher possible upside, analysts plainly believe Tilray Brands is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Cronos Group has higher earnings, but lower revenue than Tilray Brands. Cronos Group is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupC$146.59M9.24-C$32.78M-C$0.02N/A
Tilray BrandsC$858.28M1.09-C$183.24M-C$14.63N/A

Cronos Group has a net margin of -6.37% compared to Tilray Brands' net margin of -158.75%. Cronos Group's return on equity of -0.87% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group-6.37% -0.87% -3.73%
Tilray Brands -158.75%-88.06%-1.41%

Cronos Group has a beta of 1.036621, meaning that its stock price is 4% more volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 3.243166, meaning that its stock price is 224% more volatile than the S&P 500.

Summary

Cronos Group beats Tilray Brands on 9 of the 16 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilray BrandsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$932.91MC$1.63BC$6.25BC$11.72B
Dividend YieldN/A2.97%2.73%6.22%
P/E Ratio-0.534.1829.0423.83
Price / Sales1.091,488.53476.6113.46
Price / Cash5.9510.3727.6282.69
Price / Book0.5810.729.674.48
Net Income-C$183.24MC$21.15BC$3.55BC$300.68M
7 Day Performance-12.95%-1.16%1.70%0.12%
1 Month Performance-14.75%0.17%5.62%2.88%
1 Year Performance30.00%24.19%34.41%57.78%

Tilray Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray Brands
1.5363 of 5 stars
C$7.80
-3.5%
C$13.30
+70.5%
N/AC$932.91MC$858.28MN/A2,650
BHC
Bausch Health Companies
0.5693 of 5 stars
C$7.66
-1.4%
N/AN/AC$2.86BC$10.27B18.2419,900
SLS
Solaris Resources
1.6716 of 5 stars
C$13.51
-2.4%
C$19.50
+44.3%
N/AC$2.26BN/AN/A10
AUP
Aurinia Pharmaceuticals
N/AN/AN/AN/AC$2.15BC$57.59MN/A300
CARA
Cara Operations
N/AN/AN/AN/AC$1.62BN/AN/A80

Related Companies and Tools


This page (TSE:TLRY) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners